Agilon health/$AGL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Agilon health
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
Ticker
$AGL
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
1,076
ISIN
US00857U1079
Website
Agilon health Metrics
BasicAdvanced
$956M
-
-$0.59
0.39
-
Price and volume
Market cap
$956M
Beta
0.39
52-week high
$7.73
52-week low
$1.50
Average daily volume
4.1M
Financial strength
Current ratio
1.201
Quick ratio
1.18
Long term debt to equity
1.418
Total debt to equity
8.4
Interest coverage (TTM)
-46.94%
Profitability
EBITDA (TTM)
-275.284
Gross margin (TTM)
-0.33%
Net profit margin (TTM)
-4.04%
Operating margin (TTM)
-5.02%
Effective tax rate (TTM)
-0.70%
Revenue per employee (TTM)
$5,570,000
Management effectiveness
Return on assets (TTM)
-8.85%
Return on equity (TTM)
-42.97%
Valuation
Price to revenue (TTM)
0.159
Price to book
1.91
Price to tangible book (TTM)
2.34
Price to free cash flow (TTM)
-11.958
Free cash flow yield (TTM)
-8.36%
Free cash flow per share (TTM)
-19.32%
Growth
Revenue change (TTM)
23.07%
Earnings per share change (TTM)
-15.72%
3-year revenue growth (CAGR)
42.40%
3-year earnings per share growth (CAGR)
-16.13%
What the Analysts think about Agilon health
Analyst ratings (Buy, Hold, Sell) for Agilon health stock.
Bulls say / Bears say
Renaissance Technologies LLC increased its position in Agilon Health by 155.1% in the fourth quarter, indicating strong institutional confidence in the company's future prospects. (etfdailynews.com)
Agilon Health reported a net income of $12.11 million for the quarter ended March 31, 2025, surpassing analyst expectations and demonstrating improved financial performance. (tradingview.com)
Royal Bank of Canada raised its price target for Agilon Health to $3.50, reflecting a positive outlook on the company's stock. (techdows.com)
Agilon Health lowered its 2023 revenue forecast, leading to a downgrade by Leerink Partners and a reduction in the price target to $10 from $25. (tradingview.com)
The company faced a shareholder derivative lawsuit alleging misleading statements about expenses and margins, which could impact investor confidence. (bloomberglaw.com)
Agilon Health's stock price declined by approximately 28.6% following the announcement of reduced profit forecasts due to higher-than-expected medical costs. (mlq.ai)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.
Agilon health Financial Performance
Revenues and expenses
Agilon health Earnings Performance
Company profitability
Agilon health News
AllArticlesVideos
New Research Underscores the Important Role of Value-Based Care (VBC) in Improving Primary Care Access for Traditional Medicare Patients
Business Wire·3 weeks ago
INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Agilon Health, Inc. and Encourages Long-Term Agilon Investors to Contact the Firm - AGL
Accesswire·3 weeks ago
agilon health to Participate in Bernstein's 41st Annual Strategic Decisions Conference
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Agilon health stock?
Agilon health (AGL) has a market cap of $956M as of June 27, 2025.
What is the P/E ratio for Agilon health stock?
The price to earnings (P/E) ratio for Agilon health (AGL) stock is 0 as of June 27, 2025.
Does Agilon health stock pay dividends?
No, Agilon health (AGL) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Agilon health dividend payment date?
Agilon health (AGL) stock does not pay dividends to its shareholders.
What is the beta indicator for Agilon health?
Agilon health (AGL) has a beta rating of 0.39. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.